These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36322010)

  • 1. Identification of 5-(3-(methylsulfonyl)phenyl)-3-(4-(methylsulfonyl)phenyl)-3H-imidazo[4,5-b]pyridine as novel orally bioavailable and metabolically stable antimalarial compound for further exploration.
    Kundu M; Dutta A; Roy KK; Mal SK; Karmakar S; Mandal A; Mondal SK; Kumar S; Saha S; Pradhan S; Sarkar R; Chakrabarti M; Malik PK; Banerjee M
    Chem Biol Drug Des; 2023 Mar; 101(3):690-695. PubMed ID: 36322010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium.
    Liang X; Jiang Z; Huang Z; Li F; Chen C; Hu C; Wang W; Hu Z; Liu Q; Wang B; Wang L; Qi Z; Liu J; Jiang L; Liu Q
    Eur J Med Chem; 2020 Feb; 188():112012. PubMed ID: 31911293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemical screening, cytotoxicity assessment and evaluation of in vitro antiplasmodial and in vivo antimalarial activities of Mentha spicata L. methanolic leaf extract.
    Chatterjee A; Singh N; Chanu WK; Singh CB; Nagaraj VA
    J Ethnopharmacol; 2022 Nov; 298():115636. PubMed ID: 35998785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum.
    Sharma N; Mohanakrishnan D; Sharma UK; Kumar R; Richa ; Sinha AK; Sahal D
    Eur J Med Chem; 2014 May; 79():350-68. PubMed ID: 24747290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for Inhibitor Potency and Selectivity of
    Fienberg S; Eyermann CJ; Arendse LB; Basarab GS; McPhail JA; Burke JE; Chibale K
    ACS Infect Dis; 2020 Nov; 6(11):3048-3063. PubMed ID: 32966036
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplasmodial and Antimalarial Activity of 3,5-Diarylidenetetrahydro-2H-pyran-4(3H)-ones via Inhibition of Plasmodium falciparum Pyridoxal Synthase.
    Moorthy H; Yadav M; Tamang N; Mavileti SK; Singla L; Choudhury AR; Sahal D; Golakoti NR
    ChemMedChem; 2023 Jan; 18(1):e202200411. PubMed ID: 36251345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of antimalarial activity of a 3-alkylpiridine alkaloid analog by replacing the pyridine ring to a thiazole-containing heterocycle: Mode of action, mutagenicity profile, and Caco-2 cell-based permeability.
    Guimarães DSM; de Sousa Luz LS; do Nascimento SB; Silva LR; de Miranda Martins NR; de Almeida HG; de Souza Reis V; Maluf SEC; Budu A; Marinho JA; Abramo C; Carmona AK; da Silva MG; da Silva GR; Kemmer VM; Butera AP; Ribeiro-Viana RM; Gazarini ML; Júnior CSN; Guimarães L; Dos Santos FV; de Castro WV; Viana GHR; de Brito CFA; de Pilla Varotti F
    Eur J Pharm Sci; 2019 Oct; 138():105015. PubMed ID: 31344442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Development of Coumarin Derivatives as Potential Antiplasmodial and Antimalarial Agents.
    Hu XL; Gao C; Xu Z; Liu ML; Feng LS; Zhang GD
    Curr Top Med Chem; 2018; 18(2):114-123. PubMed ID: 29243579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplasmodial activity of [(aryl)arylsulfanylmethyl]Pyridine.
    Kumar S; Das SK; Dey S; Maity P; Guha M; Choubey V; Panda G; Bandyopadhyay U
    Antimicrob Agents Chemother; 2008 Feb; 52(2):705-15. PubMed ID: 18025110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice.
    Gujjar R; Marwaha A; El Mazouni F; White J; White KL; Creason S; Shackleford DM; Baldwin J; Charman WN; Buckner FS; Charman S; Rathod PK; Phillips MA
    J Med Chem; 2009 Apr; 52(7):1864-72. PubMed ID: 19296651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.
    Basilico N; Parapini S; Sparatore A; Romeo S; Misiano P; Vivas L; Yardley V; Croft SL; Habluetzel A; Lucantoni L; Renia L; Russell B; Suwanarusk R; Nosten F; Dondio G; Bigogno C; Jabes D; Taramelli D
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29194347
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ji X; Wang Z; Chen Q; Li J; Wang H; Wang Z; Yang L
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Optimization of BIPPO Analogs as Potent Antimalarials.
    Zheng Y; Matheeussen A; Maes L; Caljon G; Sterk GJ; Leurs R
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.
    Liu H; Zhou H; Cai T; Yang A; Zang M; Xing J
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
    Canfield CJ; Milhous WK; Ager AL; Rossan RN; Sweeney TR; Lewis NJ; Jacobus DP
    Am J Trop Med Hyg; 1993 Jul; 49(1):121-6. PubMed ID: 8352384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs.
    Kagami LP; das Neves GM; Rodrigues RP; da Silva VB; Eifler-Lima VL; Kawano DF
    Mol Divers; 2017 Aug; 21(3):677-695. PubMed ID: 28523625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.